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Abstract The structural requirements for internalization and
signalling of the vasopressin V1a receptor were investigated in
stably transfected HEK-293 cells. Removal of the 51 C-terminal
amino acids did not affect vasopressin binding, calcium signal-
ling, heterologous desensitization or internalization of the
receptor. Deletion of 14 additional amino acids reduced
vasopressin-dependent calcium increase and impaired receptor
internalization. Substitution of cysteines 371-372 did not affect
intracellular signalling, but decreased endocytosis by 26%.
Substitution of the 361-362 leucine by alanine residues reduced
by 56% V1a receptor sequestration without affecting calcium
signalling. These results indicate that di-cysteine and mostly di-
leucine motifs present in the C-terminal region of the V1a
receptor are involved in its internalization.
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1. Introduction
The vasopressin V1a receptor is a G protein-coupled recep-
tor whose stimulation activates membrane phospholipases CL
and generates inositol triphosphates and diacylglycerol. Ino-
sitol-1,4,5-triphosphates bind to endoplasmic reticulum recep-
tors to induce a transient rise in intracellular calcium. Dia-
cylglycerol increasing protein kinase C activity results in
phosphorylation of intracellular proteins. Stimulation of the
V1a receptor is followed by its homologous phosphorylation
and desensitization [1^4]. Similarly, stimulation of the endog-
enous muscarinic receptor m3 or direct activation of protein
kinase C induced heterologous phosphorylation and desensi-
tization of the V1a receptor when transfected in Xenopus lae-
vis or HEK-293 cells [1,2].
In addition to rapid desensitization, the V1a receptor is
internalized within minutes following its stimulation by vaso-
pressin. Di¡erent internalization pathways for membrane re-
ceptors have been described, including arrestin and caveolae-
mediated endocytosis [5]. They involve recognition sequences
between the membrane proteins and the endocytosis machin-
ery which have been identi¢ed for some proteins. These are
mostly related to serine and cysteine residues, a di-leucine
motif or complex sequences such as NPXiY, which may di¡er
from one protein to another.
The C-terminal domain of the V1a receptor contains several
motifs possibly involved in the internalization process (Fig. 1).
The 14 serine and four threonine residues are putative phos-
phorylation sites which could be involved in sequestration of
the receptor. The di-cysteine motif at positions 371 and 372 or
the cysteine at position 365 may be palmitoylated/depalmit-
oylated and participate in internalization of the receptor
through anchoring to the membrane [6]. The di-leucine motif
at position 361-362 is also a candidate for internalization and
targetting sequences [7].
To determine the possible role of these amino acids in in-
ternalization of the V1a receptor, several mutations were in-
troduced in the C-terminal domain and the mutants were
stably transfected in HEK-293 cells. These included partial
or total deletion of the C-terminal domain and substitution
of cysteine or di-leucine motifs by alanine residues. For each
mutant, the receptors a⁄nity and expression were determined
by binding experiments, intracellular signalling was character-
ized from the transient change in intracellular calcium concen-
tration and internalization was measured by an enzyme-linked
immunosorbent assay (ELISA) of epitope-tagged receptors.
2. Materials and methods
2.1. Transfection of V1a mutants in HEK-293 cells
In£uenza virus hemagglutinin epitope (Tag HA) was introduced in
the extracellular N-terminal domain of the cloned rat V1a receptor as
previously described [8]. Deletion and point mutation mutants (see
Fig. 1) were constructed with the Altered Site II in vitro mutagenesis
system (Promega) as described by the manufacturer. All cDNAs were
sequenced before expression study. The S374STOP mutant, truncated
at serine 374, lacked the last 51 amino acids of the C-terminal region.
The H360STOP mutant truncated at histidine 360 lacked the last 65
C-terminal amino acids, including cysteines 365, 371, 372 and di-leu-
cine 361-362. In the L361-362A mutant, the di-leucine motif was
replaced by di-alanine and in the C365A, the C371-372A and the
C365-371-372A mutants, cysteines were substituted by alanines.
Wild-type and mutated receptors were cloned in the expression
vector pcDNA3.1(3) (Invitrogen), which contains a geneticin resist-
ance gene, and were stably transfected in HEK-293 cells. The cells
were cultured at 37‡C under 95% air/5% CO2 in DMEM medium
containing 10% fetal calf serum, 100 U/ml penicillin, 100 Wg/ml strep-
tomycin, 0.25 Wg/ml amphotericin B (Gibco). They were plated on
30 mm dishes and transfected with the superfect reagent method
(Qiagen). The day after, cells were transferred to 100 mm dishes
and clones were selected by addition of 1 mg/ml geneticin (Gibco).
2.2. Binding experiments
The number of vasopressin binding sites at the surface of the trans-
fected cells was determined with [3H]vasopressin (NEN) on 24 well
plates. Cells were rinsed with D-PBS, 1 mM CaCl2, 0.5 mM MgCl2
(Gibco BRL) and 0.1% bovine serum albumin (BSA) and incubated
with the same solution containing 1038 M [3H]vasopressin for 45 min
at room temperature with gentle rocking. This concentration of vaso-
pressin was found saturating for V1a vasopressin binding in prelimi-
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 1 3 6 0 - 5
*Corresponding author. Fax: (33) (1) 69 08 35 70.
E-mail: corman@dsvidf.cea.fr
FEBS 22797 19-10-99
FEBS 22797 FEBS Letters 460 (1999) 303^308
nary experiments. Non-speci¢c binding was determined by addition of
1036 M vasopressin to the incubation medium. Cells were then rinsed
with D-PBS, 1 mM CaCl2, 0.5 mM MgCl2, lysed by 0.5 ml of 0.2 N
NaOH with 0.1% SDS and radioactivity was counted by liquid scin-
tillation (Tri-carb 1500 Packard). All binding determinations were
performed in duplicate.
Kd values of V1a wild-type and mutated receptors were determined
on membrane suspension prepared from T75 £asks. Cells were grown
to con£uence, harvested by trypsinization and suspended in medium
containing 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 3 mM MgSO4.
They were subsequently homogenized with a motor-driven Te£on
potter, centrifuged for 30 min (20 000Ug) at 4‡C and the pellet was
resuspended in initial bu¡er. The pellet protein content was quanti¢ed
according to Bradford’s method with BSA (Sigma) as standard and
aliquots were stored at 380‡C. Binding experiments were performed
on 50 Wg of membrane proteins in 200 Wl of initial bu¡er containing
0.1% BSA, 0.01% bacitracin and from 0.2 to 20 nM [3H]vasopressin.
Non-speci¢c binding was determined by addition of 5U1036 M AVP
to the medium. Incubations were performed for 1 h at room temper-
ature with gently rocking. The membrane suspension was thereafter
diluted in 4 ml incubation medium free of vasopressin and ¢ltered
under vacuum through a GF/C ¢lter previously coated in bu¡er me-
dium with 1% BSA for 45 min. After ¢ltration of the membrane
suspension, the ¢lter was rinsed with 4 ml of vasopressin-free incuba-
tion bu¡er, dried at 80‡C for 10 min and the radioactivity was meas-
ured by liquid scintillation counting. Kd values were determined with
the GraphPad PRISM software 2.0.
2.3. Intracellular calcium measurement
Changes in intracellular calcium were measured as previously de-
scribed [13]. Con£uent T25 £asks of the di¡erent cell lines were tryp-
sinized and loaded at room temperature for 45 min with 2 WM Fura
2-AM (Molecular Probes) in culture medium. One million cells were
introduced into a 25‡C thermostated cuvette of an Amincon Bowman
SLM 2 spectro£uorimeter. The excitation wavelengths were 340 and
380 nm and £uorescence emission was recorded at 512 nm. The ratio
between the intensity of emission following excitation at 340 and
380 nm was calculated every 0.5 s and the calcium concentration
was determined with the equation of Grynkiewicz et al. [9]. The mini-
mum ratio Rmin was obtained by addition of 5 mM EGTA and 20 WM
digitonin and the maximum ratio Rmax with 10 mM calcium.
2.4. Internalization measurements by ELISA
Stably transfected cells were cultured to con£uence on 96 well
plates. On the day of the experiment, they were rinsed with D-PBS,
1 mM CaCl2, 0.5 mM MgCl2, containing 1% BSA, and incubated
with 1037 M vasopressin for di¡erent times from 5 to 60 min. After
incubation, the cells were ¢xed with 4% paraformaldehyde, in PBS,
1 mM CaCl2, 1 mM MgCl2 for 30 min, incubated with D-PBS con-
taining 50 mM NH4Cl for 15 min and rinsed with D-PBS, 1 mM
CaCl2, 0,5 mM MgCl2 and 1% BSA. Cells were subsequently incu-
bated overnight at 4‡C with 1 Wg/ml of the anti-Tag HA antibody
(12CA5) followed by 30 min incubation at room temperature with
mouse IgG antibody coupled to horseradish peroxidase (HRP) (Prom-
ega). The optical density resulting from 30 min reaction with OPD
peroxidase substrate (Sigma) was measured at 450 nm on a multiscan
Bichromatic apparatus (Labsystem). The speci¢c optical density cor-
responding to the epitope-tagged receptors was obtained by subtrac-
tion in each experiment of the optical density of HEK-293 cells trans-
fected with non-tagged wild-type V1a receptor and treated as
previously described.
2.5. Immuno£uorescence
The cells stably transfected with the epitope-tagged V1a receptor
were plated at con£uence on glass coverslips and treated as described
for internalization measurement by ELISA until the paraformalde-
hyde ¢xation step. Cells were therefore permeabilized with 0.2% Tri-
ton X-100 for 30 min before incubation with 0.1 Wg/ml anti-Tag HA
antibody (12CA5) for 2 h at room temperature and with mouse IgG
coupled to rhodamine for 1 h. The coverslips were mounted on slides
for £uorescence microscopy.
Results are expressed as mean þ S.E.M. and statistical signi¢cance
was determined by ANOVA. Signi¢cance was set at P6 0.05
3. Results
3.1. Binding experiments
Every transfected mutant generated clones which bound
[3H]vasopressin, indicating targetting of the receptors to the
plasma membrane. As far as possible, clones with a receptor
density close to 150 000 sites/cell (125 000^230 000) were iden-
ti¢ed and characterized (Table 1). This density corresponds to
the number of vasopressin V1a receptors found in hepatocytes
by Fishman et al. [10]. However, two mutated receptors, the
one lacking its last 65 amino acids (H360STOP) and the other
with three cysteines substituted by alanine (C365-371-372A),
regularly exhibited lower expression than wild-type or other
mutated V1a receptors. For these two mutations, cell clones
Fig. 1. Schematic representation of the carboxyl-terminal region of the rat vasopressin V1a receptor, with indications of the performed trunca-
tions (H360STOP, S374STOP) and substitutions (C365A, C371-372A, C365-371-372A and L361-362A).
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with the highest V1a receptor density were selected, corre-
sponding to 35 000 sites for the H360STOP mutant and
69 000 sites for the C365-371-372A mutant (Table 1).
The Kd of epitope-tagged recombinant V1a receptor deter-
mined from binding experiments on membrane suspension
was 0.44 þ 0.05 nM (n = 7). This value was not signi¢cantly
di¡erent from the Kd of wild-type V1a receptor (0.57 þ 0.11
nM, n = 4), indicating that insertion of Tag HA at the N-
terminal region of the receptor did not modify its binding
properties. The Kd values of every tested mutant were com-
parable to that of the native receptor, with the exception of
the di-leucine-substituted mutant whose Kd was slightly, but
signi¢cantly, increased as compared to wild-type V1a receptor
(Table 1).
3.2. Calcium signalling
A representative change in intracellular calcium induced by
the addition of 1037 M vasopressin to HEK-293 cells trans-
fected with epitope-tagged V1a receptor is illustrated in Fig.
2a. Vasopressin induced a rapid and transient cytosolic calci-
um increase whose amplitude was dependent on the ligand
concentration (Fig. 2b). Every mutant exhibited a comparable
calcium increase when stimulated with 1037 M vasopressin
(Table 2), except the V1a receptor lacking 65 amino acids
(H360STOP) (Table 2). Because receptor expression of this
mutant was lower than that of the control V1a clone (Table
1), cells were incubated for 18 h with 10 mM butyrate to
increase protein expression. Rising the wild-type V1a receptor
density from 140 000 to 230 000 did not modify the calcium
peak induced by 1037 M vasopressin (213 þ 27 and 215 þ 17
nM, n = 4, respectively). Increasing the density of the
H360STOP from 35 000 to 190 000 sites/cell was associated
with a small increase in the vasopressin-dependent calcium
peak from 40 þ 12 to 103 þ 29 nM (n = 4).
3.3. Heterologous desensitization
HEK-293 cells express a m3 phospholipase CL-linked
muscarinic receptor for which stimulation by 1034 M
carbachol induced a calcium peak of mean amplitude
380 þ 45 nM (n = 25). In HEK-293 cells transfected with the
Tag HA V1a receptor, this stimulation reduced the subse-
quent increase in cytosolic calcium by 40% consecutive to
the addition of 1037 M vasopressin as compared to control
(Table 2). Heterologous desensitization of the di¡erent mu-
tants was comparable to that recorded with the wild-type
V1a receptor with the exception of the H360STOP mutant
with a reduced calcium response, which was fully desensitized
by carbachol (Table 2).
3.4. Receptor internalization
Taking advantage of the inserted Tag HA on the extracel-
lular N-terminal region of the receptor, internalization of the
wild-type V1a and mutated receptors was determined by ELI-
SA. The lack of in£uence of this external epitope on the
sequestration of the V1a receptor was ¢rst checked by binding
and immuno£uorescence experiments. Pre-incubation with
1037 M unlabelled vasopressin for 30 min of HEK-293 cells
transfected with wild-type V1a or epitope Tag HA V1a recep-
tor reduced subsequent [3H]vasopressin binding sites by 60%
(data not shown). This ability of the epitope-tagged V1a re-
ceptor to be sequestrated was con¢rmed by immuno£uores-
cence. As shown in Fig. 3, £uorescence labelling of the V1a
receptor under control conditions was di¡use at the surface of
the cell. Incubation with 1037 M vasopressin induced intra-
Table 1
Binding characteristics of wild-type and mutated V1a receptors stably transfected in HEK-293 cells
Clones Kd (nM) n Sites per cell n
V1a wild-type 0.44 þ 0.05 7 143 000 þ 8 000 9
S374STOP 0.59 þ 0.09 3 125 000 þ 20 000 5
H360STOP 0.74 þ 0.06 4 35 000 þ 6 000 6
C365A 0.80 þ 0.10 3 190 000 þ 15 000 5
C371-372A 0.54 þ 0.05 3 137 000 þ 18 000 6
C365-371-372A 0.51 þ 0.04 4 69 000 þ 6 000 6
L361-362A 1.47 þ 0.19 6 214 000 þ 20 000 6
Results are mean þ S.E.M. of n experiments.
Fig. 2. E¡ect of vasopressin on intracellular calcium increase in HEK-293 cells transfected with the rat V1a receptor. (a) Representative experi-
ment. (b) Dose-response curve of vasopressin-dependent intracellular calcium increase, mean þ S.E.M. of four experiments.
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cellular punctate £uorescence, characteristic of receptor inter-
nalization in subapical vesicles [11].
The internalization kinetics of epitope-tagged V1a receptor,
S374STOP and H360STOP mutants are presented in Fig. 4a.
In the minutes following the addition of 1037 M vasopressin,
the wild-type V1a receptor was rapidly internalized from the
cell surface. Within 30 min, 60% of the membrane receptors
were sequestrated, a value comparable to that obtained in
binding experiments. Removal of the last 51 amino acids of
the C-terminal region did not signi¢cantly modify the kinetics
and amplitude of internalization as compared to the wild-type
receptor (Fig. 4a). In contrast, deletion of the last 65 amino
acids reduced receptor internalization by 80% (Fig. 4a). Sub-
stitution of cysteine 365 by alanine did not signi¢cantly a¡ect
internalization of the receptor, whereas substitution of the di-
cysteine 371-372 motif or the three cysteines 365, 371 and 372
reduced the extent of receptor internalization by 26% (Table
2). Substitution of the di-leucine motif by alanine decreased
sequestration of the mutated receptor by 56% (Table 2 and
Fig. 4b). Because the receptor density of the L361-362A clone
was slightly larger than that of the wild-type V1a receptor
clone (230 000 versus 150 000), di-leucine mutant internaliza-
tion was further determined in another L361-362A clone with
110 000 receptors/cell. Incubation of the cells with 1037 M
vasopressin for 30 or 60 min resulted in a comparable 30%
internalization of the di-leucine-substituted V1a receptor in
the clones with 110 000 receptors/cell or with 230 000 recep-
tors/cell.
4. Discussion
Rat V1a receptor stably transfected in HEK-293 cells
shared properties with those expressed in native tissues. The
Kd of the transfected wild-type V1a receptor was comparable
to that reported by Carnazzi et al. for liver plasma membrane
[12]. Maximal internalization corresponded to a 65% decrease
in the number of surface receptors in the transfected HEK-293
cells as in vascular smooth muscle or hepatocytes within min-
utes following addition of vasopressin [10,13]. Stimulation of
the receptor with vasopressin elicited a dose-dependent tran-
sient increase in intracellular calcium, indicating functional
coupling to phospholipase CL of the V1a receptor expressed
in this heterologous expression system.
Deletion of the last 51 C-terminal amino acids of the V1a
receptor removed 17 serine-threonine residues which are pu-
tative phosphorylation sites. The deletion did not a¡ect tar-
getting to the plasma membrane, the ability to increase intra-
cellular calcium or sequestration of the mutated receptor
following vasopressin stimulation. Previous experiments in
oocytes indicated that homologous desensitization was not
altered in the same deletion mutant nor was the heterologous
desensitization in the present study [8]. This indicates that
phosphorylation of the 17 serine and threonine residues
present on the C-terminal tail is not essential for short-term
homologous and heterologous desensitization, just as it is also
not essential for sequestration of the V1a receptor. These
results are consistent with those of Murray et al. who found
unchanged internalization of opioid receptor with a truncated
C-terminal tail [14]. Similarly, Innamorati et al. showed by
deletion of the last 14 and 27 amino acids of the parent V2
receptor that phosphorylation of the C-terminal region is not
required for its internalization [15]. On the other hand, dele-
tion of the last 35 amino acids of the V2 receptor prevented
expression of the protein at the cell surface [16].
Table 2
Calcium signalling, heterologous desensitization and internalization of wild-type and mutated V1a receptors stably transfected in HEK-293 cells
Clones Calcium peak induced
by AVP 1037 M (nM)
% Desensitization induced
by 1034 M Cch
n % Internalization
at 30 min
n
V1a wild-type 206 þ 12 42 þ 3 22 64 þ 2 23
S374STOP 260 þ 21 54 þ 2 3 53 þ 4 7
H360STOP 40 þ 12 100 þ 0 4 14 þ 5 5
C365A 216 þ 10 44 þ 1 5 52 þ 7 5
C371-372A 205 þ 42 59 þ 5 3 48 þ 6 8
C365-371-372A 154 þ 28 60 þ 8 4 47 þ 5 6
L361-362A 195 þ 44 48 þ 13 4 28 þ 5 6
Results are mean þ S.E.M. of n experiments.
Fig. 3. E¡ect of 1037 M vasopressin addition for 30 min on immuno£uorescence labelling of Tag HA wild-type V1a receptors stably trans-
fected in HEK-293 cells.
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Deletion of the last 65 C-terminal amino acids of the V1a
receptor, including three cysteines and a di-leucine motif, did
not change the Kd of the receptor for vasopressin but reduced
its expression at the cell surface. Similar Kd values indicated
that the C-terminal region of the V1a receptor is not essential
for appropriate folding of the protein, whereas the e⁄ciency
of its targetting to the plasma membrane is apparently af-
fected. The stimulation of this truncated receptor by vasopres-
sin elicited a small increase in intracellular calcium as com-
pared to the wild-type receptor, whether or not its expression
was enhanced by butyrate treatment. This suggests that the C-
terminal domain of the V1a receptor is implicated in the cou-
pling with Gq protein in addition to the second intracellular
loop, as previously evidenced by Liu and Wess et al. [17].
Internalization of the V1a receptor lacking 65 C-terminal ami-
no acids was also reduced. These data are consistent with the
experiments on the angiotensin AT1A receptor, indicating that
deletion of the last 24^45 amino acids suppresses its internal-
ization [18^20]. The implication of the C-terminal region in
receptor sequestration is also supported by comparable data
obtained with PTH, substance P, histamine, endothelin or
neurokinin receptors [21^24].
The impaired sequestration of truncated receptor may be
related to the loss of an internalization motif. At least two
candidates for such motifs are present in the C-terminal do-
main of the V1a receptor, namely the cysteine and the leucine
residues. Single or double cysteine residues in the C-terminal
domain have been documented in several G protein-coupled
receptors. These are mostly located near the cytoplasmic exit
of the seventh transmembrane domain, within 20 amino acids
[6]. Palmitoylation of the cysteines favors attachment of the
C-terminal domain to the membrane, thus forming a fourth
intracellular loop. Site-directed mutagenesis of cysteine abol-
ished palmitoylation and Gs protein coupling of the L2 adre-
nergic receptor [25^26], whereas it does not a¡ect Gq coupling
of the K2A adrenergic receptor [27]. In the thyrotropin-releas-
ing hormone, substitution of cysteine by glycine did not a¡ect
the accumulation of inositol but compromised its internaliza-
tion [28]. In the V2 receptor, enhanced cell surface expression
linked to cysteine palmitoylation has been documented by
Sadhegi et al. [29]. Substitution of cysteine by serine did not
a¡ect vasopressin binding or adenylyl cyclase coupling, but
impaired V2 receptor internalization, suggesting that the pal-
mitoylation/depalmitoylation cycle is involved in endocytosis
[30].
The functional characteristics of the receptor lacking the
cysteine 365 were comparable to that of the wild-type, indicat-
ing that this amino acid alone is not essential for signalling
and endocytosis of the V1a receptor. Substitution of cysteines
371-372 by alanine has no signi¢cant e¡ect on binding proper-
ties, cell membrane expression or increase in intracellular cal-
cium induced by vasopressin. In contrast, it signi¢cantly re-
duced the amplitude of internalization, indicating that the
371-372 cysteines are partly involved in the sequestration of
the V1a receptor. This could be related to palmitoylation/de-
palmitoylation of these cysteines, as demonstrated for the V2
receptor [30]. Simultaneous substitution of cysteines 365, 371-
372 resulted in an identical Kd, a lower density of receptors at
the cell surface and a decreased internalization. Its shows that,
in addition to its role in endocytosis, cysteines are required for
full expression of the V1a receptor at the plasma membrane.
However, such a reduced membrane expression in£uences
binding properties, G protein coupling and heterologous de-
sensitization of the V1a receptor.
The implication of a di-leucine motif in sequestration has
been demonstrated for several membrane proteins including
mannose 6-phosphate, T-cell, monoamine, IgFc, prolactin and
insulin receptors [31^35]. It is also implicated in sorting of
membrane proteins in the Golgi network [33,36]. In the
present study, substitution of the di-leucine motif of the V1a
receptor with alanine slightly increased its Kd, but did not
a¡ect cell surface expression of the receptor. Neither did it
modify the increase in intracellular calcium elicited by vaso-
pressin or heterologous desensitization of the receptor. In
contrast, despite comparable membrane expression and calci-
um signalling, the sequestration of the V1a receptor was
markedly reduced by removal of the di-leucine motif, as it
was by truncation of the last 65 amino acids including this
di-leucine motif.
In summary, neither deletion of the C-terminal region nor
substitution of cysteine residues a¡ects vasopressin binding to
V1a receptor. The deletion of the last 51 amino acids did not
alter signalling, internalization or heterologous desensitization
of the V1a receptor, whereas deletion of 14 additional amino
Fig. 4. Internalization of wild-type and mutated rat V1a receptors stably transfected in HEK-293 cells. Results are expressed in % of control,
which corresponded for each clone to cells incubated in the absence of vasopressin. (a) E¡ect of truncations of the last 51 (S374STOP) or 65
(H360STOP) C-terminal amino acids. (b) E¡ect of substitution of the di-leucine motif 361-362 by alanine residues.
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acids impaired sequestration and calcium signalling. Substitu-
tion of individual amino acids indicated that cysteine residues
which are putative sites of palmitoylation are not essential for
G protein coupling and heterologous desensitization, but are
partly implicated in internalization of the V1a receptor ex-
pressed in HEK-293 cells. The di-leucine motif present in
the C-terminal region is not required for appropriate target-
ting to the cell membrane, for calcium signalling or for het-
erologous desensitization of the V1a receptor, but would be a
major recognition sequence for its internalization.
Acknowledgements: We are grateful to Marion Lambert for her ¢rst
class technical assistance.
References
[1] Ancellin, N. and Morel, A. (1998) Cell. Signal. 10, 17^23.
[2] Ancellin, N., Preisser, L., Le Maout, S., Barbado, M., Creminon,
C., Corman, B. and Morel, A. Homologous and heterologous
phosphorylation of the vasopressin V1a receptor, (1999) Cell.
Signal. 11 (10), 743^751.
[3] Innamorati, G., Sadhegi, H. and Birnbaumer, M. (1998) J. Biol.
Chem. 273, 7155^7161.
[4] Nathanson, M., Burgsthaler, A., Orlo¡, J., Mani, A. and Moyer,
S. (1994) Am. J. Physiol. 267, C94^C103.
[5] Zhang, M., Ferguson, S., Barak, L., Aber, M., Giros, B., Lefko-
witz, R. and Caron, M. (1997) Recept. Channels 5, 193^199.
[6] Morello, J.P. and Bouvier, M. (1996) Cell Biol. 74, 449^457.
[7] Gabilondo, A., Hegler, J., Krasel, C., Boivin-Jahns, V. and Hein,
L. (1997) Proc. Natl. Acad. Sci. USA 94, 12285^12290.
[8] Ancellin, N., Preisser, L., Corman, B. and Morel, A. (1997)
FEBS Lett. 41, 323^326.
[9] Grynkiewicz, G., Poenie, M. and Tsien, R. (1985) J. Biol. Chem.
360, 3440^3450.
[10] Fishman, J., Dickey, B., Bucher, N. and Fine, R. (1985) J. Biol.
Chem. 260, 12641^12646.
[11] Lutz, W., Sanders, M., Salisbury, J. and Kumar, R. (1990) Proc.
Natl. Acad. Sci. USA 87, 6507^6511.
[12] Carnazzi, E., Aumelas, A., Barberis, C., Guillon, G. and Seyer,
R. (1994) J. Med. Chem. 37, 1841^1849.
[13] Briner, V., Williams, B., Tsai, P. and Shrier, R. (1992) Proc.
Natl. Acad. Sci. USA 89, 2854^2858.
[14] Murray, S., Evans, C. and Von Zastrow, M. (1998) J. Biol.
Chem. 273, 24987^24991.
[15] Innamorati, G., Sadeghi, H., Eberle, A. and Birnbaumer, M.
(1997) J. Biol. Chem. 274, 2486^2492.
[16] Oksche, A., Dehe, M., Schu«lein, R., Wiesner, B. and Rosenthal,
W. (1998) FEBS Lett. 424, 57^62.
[17] Liu, J. and Wess, J. (1996) J. Biol. Chem. 271, 8772^8778.
[18] Conchon, S., Peltier, N., Corvol, P. and Clauzer, E. (1998) Am.
J. Physiol. 274, E336^E345.
[19] Thomas, W., Thekkumkara, T., Motel, T. and Baker, K. (1995)
J. Biol. Chem. 270, 207^213.
[20] Balmforth, A., Lee, A., Bajaj, B., Dickinson, C., Warburton, P.
and Ball, S. (1995) Eur. J. Pharmacol. 291, 135^141.
[21] Schneider, H., Feyen, J. and Seuwen, K. (1994) FEBS Lett. 351,
281^285.
[22] Sasakawa, N., Sharif, M. and Hanley, M.R. (1994) FEBS Lett.
347, 181^184.
[23] Fukushima, Y., Asano, T., Takata, K., Funaki, M., Ogihara, T.,
Anai, M., Tsukuda, K., Saitoh, T., Katagiri, H., Aihara, M.,
Matsuhashi, N., Oka, Y., Yazaki, Y. and Sugano, K. (1997)
J. Biol. Chem. 272, 19464^19470.
[24] Cyr, C., Rudy, B. and Kris, R. (1993) J. Biol. Chem. 268, 26071^
26074.
[25] O’Dowd, B., Hnatowich, M., Caron, M., Lefkowitz, R. and
Bouvier, M. (1989) J. Biol. Chem. 264, 7564^7569.
[26] Mo¡et, S., Mouillac, B., Bonin, H., Loisel, T. and Bouvier, M.
(1993) EMBO J. 12, 349^356.
[27] Kennedy, M. and Limbird, L. (1993) J. Biol. Chem. 268, 8003^
8011.
[28] Nussenzveig, D., Hein£ink, M. and Gershengorn, M. (1993)
J. Biol. Chem. 268, 2389^2392.
[29] Sadhegi, H., Innamorati, G., Dagarag, M. and Birnbaumer, M.
(1997) Mol. Pharmacol. 52, 21^29.
[30] Schu«lein, R., Liebenho¡, U., Mu«ller, H., Birnbaumer, M. and
Rosenthal, W. (1996) Biochem. J. 313, 611^616.
[31] Denzer, K., Weber, B., Hille-Rehfeld, A., von Figura, K. and
Pohlmann, R. (1997) Biochem. J. 326, 497^505.
[32] Haft, C., Klausner, R. and Taylor, S. (1994) J. Biol. Chem. 269,
26286^26294.
[33] Hunziger, W. and Fumey, C. (1994) EMBO J. 13, 2939^2963.
[34] Letourneur, F. and Klausner, R.D. (1992) Cell 69, 1143^1157.
[35] Vincent, V., Go⁄n, V., Rozakis-Adcock, M., Mornon, J.P. and
Kelly, P. (1997) J. Biol. Chem. 272, 7062^7068.
[36] Melvin, D., Marsh, B., Walmsley, A., James, D. and Gould, G.
(1999) Biochemistry 38, 1456^1462.
FEBS 22797 19-10-99
L. Preisser et al./FEBS Letters 460 (1999) 303^308308
